Recipient adverse effects
| . | Patients . | Transfusions . |
|---|---|---|
| Chills | 7/19 (37%) | 12/165 (7%) |
| >1.5°C temp rise | 6/19 (32%) | 12/165 (7%) |
| Itching/hives | 2/19 (11%) | 3/165 (2%) |
| Temperature (C°) | O2 Saturation (%) | |
| Pretransfusion | 37.1 ± 0.9 (35.0-39.9) | 95.3 ± 3.8 (61-100) |
| Change 2° transfusion | 0.2 ± 0.9 ((−2.4)-3.8) | 0.5 ± 2.9 ((−16)-13) |
| . | Patients . | Transfusions . |
|---|---|---|
| Chills | 7/19 (37%) | 12/165 (7%) |
| >1.5°C temp rise | 6/19 (32%) | 12/165 (7%) |
| Itching/hives | 2/19 (11%) | 3/165 (2%) |
| Temperature (C°) | O2 Saturation (%) | |
| Pretransfusion | 37.1 ± 0.9 (35.0-39.9) | 95.3 ± 3.8 (61-100) |
| Change 2° transfusion | 0.2 ± 0.9 ((−2.4)-3.8) | 0.5 ± 2.9 ((−16)-13) |
Ranges in parentheses.